Related Experiment Video
Updated: May 22, 2026
The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
Published on: August 16, 2014
Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody
Gao-Qin Liu1, Pei-Rong Lu, Long-Biao Li
1Department of Ophthalmology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China.
Aim:
To explore the effect of SDF-1α on the development of experimental corneal neovascularization (CRNV).
Methods:
CRNV was induced by alkali injury in mice. The expression of SDF-1α and CXCR4 in burned corneas was examined by Flow Cytometry. Neutralizing anti-mouse SDF-1α antibody was locally administrated after alkali injury and the formation of CRNV 2 weeks after injury was assessed by Immunohistochemistry. The expression of VEGF and C-Kit in burned corneas was detected by RT-PCR.
Results:
The number of CRNV peaks at 2 weeks after alkali injury. Compared to control group, SDF-1α neutralizing antibody treatment significantly decreased the number of CRNV. RT-PCR confirmed that SDF-1α neutralizing antibody treatment resulted in decreased intracorneal VEGF and C-Kit expression.
Conclusion:
SDF-1α neutralizing antibody treated mice exhibited impaired experimental CRNV through down regulated VEGF and C-Kit expression.
Insights
This study shows that blocking SDF-1α (stromal cell-derived factor 1-alpha) significantly reduces corneal neovascularization in mice. This therapeutic approach downregulates key factors involved in blood vessel growth.
Area of Science:
- Ophthalmology
- Vascular Biology
- Immunology
Background:
- Corneal neovascularization (CRNV) is a significant cause of vision impairment.
- Stromal cell-derived factor 1-alpha (SDF-1α) is implicated in inflammatory and angiogenic processes.
Purpose of the Study:
- To investigate the role of SDF-1α in the development of experimental corneal neovascularization (CRNV).
- To evaluate the therapeutic potential of targeting SDF-1α in CRNV.
Main Methods:
- CRNV was induced in mice via alkali injury.
- SDF-1α and CXCR4 expression analyzed by Flow Cytometry.
- Anti-SDF-1α neutralizing antibody administered to assess CRNV formation and VEGF/C-Kit expression via RT-PCR.
Main Results:
- CRNV formation peaked at 2 weeks post-injury.
- SDF-1α neutralizing antibody treatment significantly reduced CRNV.
- Intracorneal VEGF and C-Kit expression were downregulated following antibody treatment.
Conclusions:
- SDF-1α plays a critical role in promoting experimental CRNV.
- Neutralizing SDF-1α inhibits CRNV development by downregulating VEGF and C-Kit.
- Targeting SDF-1α represents a potential therapeutic strategy for corneal neovascularization.
More Related Videos
10:52An Alkali-burn Injury Model of Corneal Neovascularization in the Mouse
Published on: April 7, 2014
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016